SELEX—A (r)evolutionary method to generate high-affinity nucleic acid ligands
Tóm tắt
Từ khóa
Tài liệu tham khảo
Allen, 1995, Isolation of high-affinity rna ligands to Hiv-1 integrase from A random pool, Virology, 209, 327, 10.1006/viro.1995.1264
Andre, 2006, Enantioselective aptameric molecular recognition material: design of a novel chiral stationary phase for enantioseparation of a series of chiral herbicides by capillary electrochromatography, Electrophoresis, 27, 3254, 10.1002/elps.200500070
Andreola, 2000, Towards the selection of phosphorothioate aptamers—optimizing in vitro selection steps with phosphorothioate nucleotides, Eur. J. Biochem., 267, 5032, 10.1046/j.1432-1327.2000.01557.x
Andreola, 2001, DNA aptamers selected against the HIV-1 RNase H display in vitro antiviral activity, Biochemistry, 40, 10087, 10.1021/bi0108599
Asai, 2004, In vitro selection of DNA aptamers on chips using a method for generating point mutations, Anal. Lett., 37, 645, 10.1081/AL-120029741
Beinoraviciute-Kellner, 2005, In vitro selection of DNA binding sites for ABF1 protein from Saccharomyces cerevisiae, FEBS Lett., 579, 4535, 10.1016/j.febslet.2005.07.009
Berens, 2001, A tetracycline-binding RNA aptamer, Bioorg. Med. Chem., 9, 2549, 10.1016/S0968-0896(01)00063-3
Bianchini, 2001, Specific oligobodies against ERK-2 that recognize both the native and the denatured state of the protein, J. Immunol. Methods, 252, 191, 10.1016/S0022-1759(01)00350-7
Biesecker, 1999, Derivation of RNA aptamer inhibitors of human complement C5, Immunopharmacology, 42, 219, 10.1016/S0162-3109(99)00020-X
Bittker, 2002, Nucleic acid evolution and minimization by nonhomologous random recombination, Nat. Biotechnol., 20, 1024, 10.1038/nbt736
Blank, 2001, Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels—selective targeting of endothelial regulatory protein pigpen, J. Biol. Chem., 276, 16464, 10.1074/jbc.M100347200
Bock, 1992, Selection of single-stranded DNA molecules that bind and inhibit human thrombin, Nature, 355, 564, 10.1038/355564a0
Boiziau, 1999, DNA aptamers selected against the HIV-1 trans-activation-responsive RNA element form RNA-DNA kissing complexes, J. Biol. Chem., 274, 12730, 10.1074/jbc.274.18.12730
Bridonneau, 1999, Site-directed selection of oligonucleotide antagonists by competitive elution, Antisens. Nucleic A, 9, 1, 10.1089/oli.1.1999.9.1
Brockstedt, 2004, In vitro evolution of RNA aptamers recognizing carcinogenic aromatic amines, Biochem. Biophys. Res. Commun., 313, 1004, 10.1016/j.bbrc.2003.12.030
Brody, 1999, The use of aptamers in large arrays for molecular diagnostics, Mol. Diagn., 4, 381, 10.1016/S1084-8592(99)80014-9
Brown, 1997, Single-stranded RNA recognition by the bacteriophage T4 translational repressor, RegA, J. Biol. Chem., 272, 14969, 10.1074/jbc.272.23.14969
Bruno, 1997, In vitro selection of DNA to chloroaromatics using magnetic microbead-based affinity separation and fluorescence detection, Biochem. Biophys. Res. Commun., 234, 117, 10.1006/bbrc.1997.6517
Bruno, 1999, In vitro selection of DNA aptamers to anthrax spores with electrochemiluminescence detection, Biosens. Bioelectron., 14, 457, 10.1016/S0956-5663(99)00028-7
Burgstaller, 1994, Isolierung von RNA Aptameren für biologische Cofaktoren durch in-vitro Selektion, Angew. Chem., 106, 1163, 10.1002/ange.19941061021
Burgstaller, 2002, Aptamers as tools for target prioritization and lead identification, Drug Discov. Today, 7, 1221, 10.1016/S1359-6446(02)02522-9
Burke, 1997, RNA aptamers to the adenosine moiety of S-adenosyl methionine: structural inferences from variations on a theme and the reproducibility of SELEX, Nucleic Acids Res., 25, 2020, 10.1093/nar/25.10.2020
Burke, 1997, RNA aptamers to the peptidyl transferase inhibitor chloramphenicol, Chem. Biol., 4, 833, 10.1016/S1074-5521(97)90116-2
Burke, 1996, Bent pseudoknots and novel RNA inhibitors of type 1 human immunodeficiency virus (HIV-1) reverse transcriptase, J. Mol. Biol., 264, 650, 10.1006/jmbi.1996.0667
Burke, 1998, Recombination, RNA evolution, and bifunctional RNA molecules isolated through chimeric SELEX, RNA, 4, 1165, 10.1017/S1355838298980542
Burmeister, 2005, Direct in vitro selection of a 2′-O-methyl aptamer to VEGF, Chem. Biol., 12, 25, 10.1016/j.chembiol.2004.10.017
Cassiday, 2003, Yeast genetic selections to optimize RNA decoys for transcription factor NF-kappa B, Proc. Natl. Acad. Sci. U. S. A., 100, 3930, 10.1073/pnas.0736013100
Chaloin, 2002, Endogenous expression of a high-affinity pseudoknot RNA aptamer suppresses replication of HIV-1, Nucleic Acids Res., 30, 4001, 10.1093/nar/gkf522
Chapman, 2006, Pegaptanib: a novel approach to ocular neovascularization, Ann. Pharmacother., 40, 1322, 10.1345/aph.1G604
Chen, 2003, The fragile X mental retardation protein binds and regulates a novel class of mRNAs containing U rich target sequences, Neuroscience, 120, 1005, 10.1016/S0306-4522(03)00406-8
Chenna, 2003, Multiple sequence alignment with the clustal series of programs, Nucleic Acids Res., 31, 3497, 10.1093/nar/gkg500
Cho, 2004, In vitro selection of specific RNA aptamers for the NFAT DNA binding domain, Mol. Cells, 18, 17, 10.1016/S1016-8478(23)13076-7
Cho, 2004, Microbead-based affinity chromatography chip using RNA aptamer modified with photocleavable linker, Electrophoresis, 25, 3730, 10.1002/elps.200406103
Chung, 2005, Microaffinity purification of proteins based on photolytic elution: toward an efficient microbead affinity chromatography on a chip, Electrophoresis, 26, 694, 10.1002/elps.200410005
Ciesiolka, 1995, Selection of an RNA domain that binds Zn2+, RNA, 1, 538
Clark, 2002, Aptamers as analytical reagents, Electrophoresis, 23, 1335, 10.1002/1522-2683(200205)23:9<1335::AID-ELPS1335>3.0.CO;2-E
Connor, 2006, Aptamer stationary phase for protein capture in affinity capillary chromatography, J. Chromatogr. A, 1111, 115, 10.1016/j.chroma.2005.05.012
Conrad, 1995, In vitro selection methodologies to probe RNA function and structure, Mol. Div., 1, 69, 10.1007/BF01715810
Coulter, 1997, Identification of a new class of exonic splicing enhancers by in vivo selection, Mol. Cell. Biol., 17, 2143, 10.1128/MCB.17.4.2143
Cox, 2001, Automated selection of anti-protein aptamers, Bioorg. Med. Chem., 9, 2525, 10.1016/S0968-0896(01)00028-1
Cox, 2002, Automated selection of aptamers against protein targets translated in vitro: from gene to aptamer, Nucleic Acids Res., 30, e108, 10.1093/nar/gnf107
Cox, 2002, Automated acquisition of aptamer sequences, Comb. Chem. High T. Scr., 5, 289
Dang, 1996, Oligonucleotide inhibitors of Taq DNA polymerase facilitate detection of low copy number targets by PCR, J. Mol. Biol., 264, 268, 10.1006/jmbi.1996.0640
Daniels, 2003, A tenascin-C aptamer identified by tumor cell SELEX: systematic evolution of ligands by exponential enrichment, Proc. Natl. Acad. Sci. U. S. A., 100, 15416, 10.1073/pnas.2136683100
Daniels, 2002, Generation of RNA aptamers to the G-protein-coupled receptor for neurotensin, NTS-1, Anal. Biochem., 305, 214, 10.1006/abio.2002.5663
Darfeuille, 2004, LNA/DNA chimeric oligomers mimic RNA aptamers targeted to the TAR RNA element of HIV-1, Nucleic Acids Res., 32, 3101, 10.1093/nar/gkh636
Davis, 2002, Isolation of high-affinity GTP aptamers from partially structured RNA libraries, Proc. Natl. Acad. Sci. U. S. A., 99, 11616, 10.1073/pnas.182095699
Davis, 1997, Use of a high affinity DNA ligand in flow cytometry (Reprinted from Nucleic Acids Research), J. Clin. Ligand Assay, 20, 90
Davis, 1998, Staining of cell surface human CD4 with 2′-F-pyrimidine-containing RNA aptamers for flow cytometry, Nucleic Acids Res., 26, 3915, 10.1093/nar/26.17.3915
Deng, 2001, Retention and separation of adenosine and analogues by affinity chromatography with an aptamer stationary phase, Anal. Chem., 73, 5415, 10.1021/ac0105437
Dobbelstein, 1995, In-vitro selection of rna ligands for the ribosomal L22 protein associated with Epstein-Barr virus-expressed RNA by using randomized and CDNA-derived RNA libraries, J. Virol., 69, 8027, 10.1128/JVI.69.12.8027-8034.1995
Dougan, 2000, Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood, Nucl. Med. Biol., 27, 289, 10.1016/S0969-8051(99)00103-1
Drabovich, 2006, Selection of smart aptamers by methods of kinetic capillary electrophoresis, Anal. Chem., 78, 3171, 10.1021/ac060144h
Drolet, 1996, An enzyme-linked oligonucleotide assay, Nat. Biotechnol., 14, 1021, 10.1038/nbt0896-1021
Duconge, 1999, In vitro selection identifies key determinants for loop-loop interactions: RNA aptamers selective for the TAR RNA element of HIV-1, RNA-A, 5, 1605, 10.1017/S1355838299991318
Dyke, 2006, First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology, Circulation, 114, 2490, 10.1161/CIRCULATIONAHA.106.668434
Ellington, 1990, In vitro selection of RNA molecules that bind specific ligands, Nature, 346, 818, 10.1038/346818a0
Ellington, 1992, Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures, Nature, 355, 850, 10.1038/355850a0
Eulberg, 2005, Development of an automated in vitro selection protocol to obtain RNA-based aptamers: identification of a biostable substance P antagonist, Nucleic Acids Res., 33, e45, 10.1093/nar/gni044
Famulok, 1994, Molecular recognition of amino-acids by RNA–aptamers—an l-citrulline binding RNA motif and its evolution into an l-arginine binder, J. Am. Chem. Soc., 116, 1698, 10.1021/ja00084a010
Famulok, 1999, Oligonucleotide aptamers that recognize small molecules, Curr. Opin. Struct. Biol., 9, 324, 10.1016/S0959-440X(99)80043-8
Famulok, 2001, Intramers as promising new tools in functional proteomics, Chem. Biol., 8, 931, 10.1016/S1074-5521(01)00070-9
Famulok, 1992, Stereospecific recognition of tryptophan agarose by in vitro selected RNA, J. Am. Chem. Soc., 114, 3990, 10.1021/ja00036a065
Faulhammer, 2004, Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ, RNA-A, 10, 516, 10.1261/rna.5186504
Ferreira, 2006, DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers, Tumor Biol., 27, 289, 10.1159/000096085
Forster, 2006, Comparative crystallization and preliminary X-ray diffraction studies of locked nucleic acid and RNA stems of a tenascin C-binding aptamer, Acta Crystallogr. F, 62, 665, 10.1107/S1744309106020343
Fukusaki, 2000, DNA aptamers that bind to chitin, Bioorg. Med. Chem. Lett., 10, 423, 10.1016/S0960-894X(00)00013-5
Gebhardt, 2000, RNA aptamers to S-adenosylhomocysteine: kinetic properties, divalent cation dependency, and comparison with anti-S-adenosylhomocysteine antibody, Biochemistry, 39, 7255, 10.1021/bi000295t
Geiger, 1996, RNA aptamers that bind l-arginine with sub-micromolar dissociation constants and high enantioselectivity, Nucleic Acids Res., 24, 1029, 10.1093/nar/24.6.1029
German, 1998, Aptamers as ligands in affinity probe capillary electrophoresis, Anal. Chem., 70, 4540, 10.1021/ac980638h
Gold, 1997, From oligonucleotide shapes to genomic SELEX: novel biological regulatory loops, Proc. Natl. Acad. Sci. U. S. A., 94, 59, 10.1073/pnas.94.1.59
Gold, 1995, Diversity of oligonucleotide functions, Annu. Rev. Biochem., 64, 763, 10.1146/annurev.bi.64.070195.003555
Gold, 1997, SELEX and the evolution of genomes, Curr. Opin. Genet. Dev., 7, 848, 10.1016/S0959-437X(97)80050-0
Golden, 2000, Diagnostic potential of PhotoSELEX-evolved ssDNA aptamers, J. Biotechnol., 81, 167, 10.1016/S0168-1656(00)00290-X
Gopinath, 2007, Methods developed for SELEX, Anal. Bioanal. Chem., 387, 171, 10.1007/s00216-006-0826-2
Gopinath, 2006, An RNA aptamer that distinguishes between closely related human influenza viruses and inhibits haemagglutinin-mediated membrane fusion, J. Gen. Virol., 87, 479, 10.1099/vir.0.81508-0
Göringer, 2003, In vitro selection of high-affinity nucleic acid ligands to parasite target molecules, Int. J. Parasitol., 33, 1309, 10.1016/S0020-7519(03)00197-8
Grate, 2001, Inducible regulation of the S-cerevisiae cell cycle mediated by an RNA aptamer–ligand complex, Bioorg. Med. Chem., 9, 2565, 10.1016/S0968-0896(01)00031-1
Green, 1995, Nuclease-resistant nucleic-acid ligands to vascular-permeability factor vascular endothelial growth-factor, Chem. Biol., 2, 683, 10.1016/1074-5521(95)90032-2
Green, 1996, Inhibitory DNA ligands to platelet-derived growth factor B-chain, Biochemistry, 35, 14413, 10.1021/bi961544+
Guthold, 2002, Novel methodology to detect, isolate, amplify and characterize single aptamer molecules with desirable target-binding properties, Biophys. J., 82, 163A
Haes, 2006, Aptamer-based detection and quantitative analysis of ricin using affinity probe capillary electrophoresis, Anal. Chem., 78, 3758, 10.1021/ac060021x
Haller, 1997, In vitro selection of a 7-methyl-guanosine binding RNA that inhibits translation of capped mRNA molecules, Proc. Natl. Acad. Sci. U. S. A., 94, 8521, 10.1073/pnas.94.16.8521
Harada, 1995, Identification of two novel arginine binding DNAs, EMBO J., 14, 5798, 10.1002/j.1460-2075.1995.tb00268.x
Held, 2003, Evolutionary landscapes for the acquisition of new ligand recognition by RNA aptamers, J. Mol. Evol., 57, 299, 10.1007/s00239-003-2481-y
Hendry, 1996, Detection and quantitation of unlabeled nucleic acids in polyacrylamide gels, Biotechniques, 20, 258, 10.2144/96202rr03
Hermann, 2000, Adaptive recognition by nucleic acid aptamers, Science, 287, 820, 10.1126/science.287.5454.820
Herr, 2006, Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells, Anal. Chem., 78, 2918, 10.1021/ac052015r
Hesselberth, 2000, In vitro selection of RNA molecules that inhibit the activity of ricin A-chain, J. Biol. Chem., 275, 4937, 10.1074/jbc.275.7.4937
Hicke, 2006, Tumor targeting by an aptamer, J. Nucl. Med., 47, 668
Hicke, 2000, Escort aptamers: a delivery service for diadnosis and therapy, J. Clin. Invest., 106, 923, 10.1172/JCI11324
Hicke, 2001, tenascin-c aptamers are generated using tumor cells and purified protein, J. Biol. Chem., 276, 48644, 10.1074/jbc.M104651200
Hicke, 1996, DNA aptamers block l-selectin function in vivo. Inhibition of human lymphocyte trafficking in SCID mice, J. Clin. Invest., 98, 2688, 10.1172/JCI119092
Hirao, 2004, In vitro selection of RNA aptamers that bind to colicin E3 and structurally resemble the decoding site of 16S ribosomal RNA, Biochemistry, 43, 3214, 10.1021/bi0356146
Hofmann, 1997, Ni2+-binding RNA motifs with an asymmetric purine-rich internal loop and a G-A base pair, RNA, 3, 1289
Homann, 1999, Combinatorial selection of high affinity RNA ligands to live African trypanosomes, Nucleic Acids Res., 27, 2006, 10.1093/nar/27.9.2006
Horn, 2004, The crystal structure of a high affinity RNA stem-loop complexed with the bacteriophage MS2 capsid: further challenges in the modeling of ligand-RNA interactions, RNA-A, 10, 1776, 10.1261/rna.7710304
Huang, 2003, Evolution of aptamers with secondary structures from a new specificity and new an ATP aptamer, RNA-A, 9, 1456, 10.1261/rna.5990203
Huizenga, 1995, A DNA aptamer that binds adenosine and ATP, Biochemistry., 34, 656, 10.1021/bi00002a033
Hwang, 2002, Improvement of RNA aptamer activity against myasthenic autoantibodies by extended sequence selection, Biochem. Biophys. Res. Commun., 290, 656, 10.1006/bbrc.2001.6252
Hybarger, 2006, A microfluidic SELEX prototype, Anal. Bioanal. Chem., 384, 191, 10.1007/s00216-005-0089-3
James, 2000, Aptamers, 4848
Jayasena, 1999, Aptamers: an emerging class of molecules that rival antibodies in diagnostics, Clin. Chem., 45, 1628, 10.1093/clinchem/45.9.1628
Jellinek, 1994, Inhibition of receptor binding by high-affinity RNA ligands to vascular endothelial growth factor, Biochemistry, 33, 10450, 10.1021/bi00200a028
Jenison, 1994, High-resolution molecular discrimination by RNA, Science, 263, 1425, 10.1126/science.7510417
Jensen, 1995, Using in vitro selection to direct the covalent attachment of human immunodeficiency virus type 1 Rev protein to high-affinity RNA ligands, Proc. Natl. Acad. Sci. U. S. A., 92, 12220, 10.1073/pnas.92.26.12220
Jeon, 2004, A DNA aptamer prevents influenza infection by blocking the receptor binding region of the viral hemagglutinin, J. Biol. Chem., 279, 48410, 10.1074/jbc.M409059200
Jeong, 2001, In vitro selection of the RNA aptamer against the Sialyl Lewis X and its inhibition of the cell adhesion, Biochem. Biophys. Res. Commun., 281, 237, 10.1006/bbrc.2001.4327
Jhaveri, 1998, In vitro selection of phosphorothiolated aptamers, Bioorg. Med. Chem. Lett., 8, 2285, 10.1016/S0960-894X(98)00414-4
Jiang, 1997, Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex, Chem. Biol., 4, 35, 10.1016/S1074-5521(97)90235-0
Johnson, 1999, RNA binding characteristics and overall topology of the vaccinia poly(A) polymerase-processivity factor-primer complex, Nucleic Acids Res., 27, 2708, 10.1093/nar/27.13.2708
Jones, 2006, High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity, Antimicrob. Agents Ch., 50, 3019, 10.1128/AAC.01603-05
Kato, 2000, In vitro selection of DNA aptamers which bind to cholic acid, Biochim. Biophys. Acta, 1493, 12, 10.1016/S0167-4781(00)00080-4
Kawakami, 2000, In vitro selection of aptamers that act with Zn2+, J. Inorg. Biochem., 82, 197, 10.1016/S0162-0134(00)00158-6
Kawazoe, 1996, Patterned staining by fluorescein-labeled oligonucleotides obtained by in vitro selection, Anal. Chem., 68, 4309, 10.1021/ac960684m
Kelly, 1996, Reconciliation of the X-ray and NMR structures of the thrombin-binding aptamer d(GGTTGGTGTGGTTGG), J. Mol. Biol., 256, 417, 10.1006/jmbi.1996.0097
Kiga, 1998, An RNA aptamer to the xanthine/guanine base with a distinctive mode of purine recognition, Nucleic Acids Res., 26, 1755, 10.1093/nar/26.7.1755
Kikuchi, 2003, RNA aptamers targeted to domain II of hepatitis C virus IRES that bind to its apical loop region, J. Biochem., 133, 263, 10.1093/jb/mvg036
Kim, 2002, Selection and stabilization of the RNA aptamers against the human immunodeficiency virus type-1 nucleocapsid protein, Biochem. Biophys. Res. Commun., 291, 925, 10.1006/bbrc.2002.6521
Kimoto, 2004, Site-specific incorporation of a photo-crosslinking component into RNA by T7 transcription mediated by unnatural base pairs, Chem. Biol., 11, 47, 10.1016/j.chembiol.2003.12.016
Kimoto, 2002, Anti-(Raf-1) RNA aptamers that inhibit Ras-induced Raf-1 activation, Eur. J. Biochem., 269, 697, 10.1046/j.0014-2956.2001.02703.x
King, 2002, Combinatorial selection and binding of phosphorothioate aptamers targeting human NF-kappa B RelA(p65) and p50, Biochemistry, 41, 9696, 10.1021/bi020220k
Kirby, 2004, Aptamer-based sensor arrays for the detection and quantitation of proteins, Anal. Chem., 76, 4066, 10.1021/ac049858n
Kleinjung, 1998, High-affinity RNA as a recognition element in a biosensor, Anal. Chem., 70, 328, 10.1021/ac9706483
Klug, 1999, In vitro selection of RNA aptamers that bind special elongation factor SelB, a protein with multiple RNA-binding sites, reveals one major interaction domain at the carboxyl terminus, RNA, 5, 1180, 10.1017/S135583829999088X
Klussmann, 2006
Klussmann, 1996, Mirror-image RNA that binds d-adenosine, Nat. Biotechnol., 14, 1112, 10.1038/nbt0996-1112
Ko, 2001, Identification of a structural motif of 23S rRNA interacting with 5S rRNA, FEBS Lett., 508, 300, 10.1016/S0014-5793(01)03068-X
Ko, 1999, Probing the functional motifs of Escherichia coli 5S rRNA in relation to 16S rRNA using a SELEX experiment, Br. Kor. Chem. Soc., 20, 1335
Koizumi, 2000, Molecular recognition of cAMP by an RNA aptamer, Biochemistry, 39, 8983, 10.1021/bi000149n
Kopylov, 2000, Combinatorial chemistry of nucleic acids: SELEX, Mol. Biol., 34, 940, 10.1023/A:1026696330245
Kotia, 2000, Separation of nontarget compounds by DNA aptamers, Anal. Chem., 72, 827, 10.1021/ac991112f
Kubik, 1997, Isolation and characterization of 2′-fluoro-, 2′-amino-, and 2′-fluoro/amino-modified RNA ligands to human IFN-gamma that inhibit receptor binding, J. Immunol., 159, 259, 10.4049/jimmunol.159.1.259
Kumar, 1997, Isolation of RNA aptamers specific to the NS3 protein of hepatitis C virus from a pool of completely random RNA, Virology, 237, 270, 10.1006/viro.1997.8773
Kusser, 2000, Chemically modified nucleic acid aptamers for in vitro selections: evolving evolution, J. Biotechnol., 74, 27
Kuwahara, 2006, Direct PCR amplification of various modified DNAs having amino acids: convenient preparation of DNA libraries with high-potential activities for in vitro selection, Bioorg. Med. Chem., 14, 2518, 10.1016/j.bmc.2005.11.030
Kwon, 2001, In vitro selection of RNA against kanamycin B, Mol. Cells, 11, 303, 10.1016/S1016-8478(23)17040-3
Lato, 1995, In-vitro selection of RNA lectins—using combinatorial chemistry to interpret ribozyme evolution, Chem. Biol., 2, 291, 10.1016/1074-5521(95)90048-9
Lato, 1996, Screening chemical libraries for nucleic-acid-binding drugs by in vitro selection: a test case with lividomycin, Mol. Div., 2, 103, 10.1007/BF01718707
Lauhon, 1995, RNA aptamers that bind flavin and nicotinamide redox cofactors, J. Am. Chem. Soc., 117, 1246, 10.1021/ja00109a008
Lee, 2006, Aptamer therapeutics advance, Curr. Opin. Chem. Biol., 10, 282, 10.1016/j.cbpa.2006.03.015
Lee, 2000, A fiber-optic microarray biosensor using aptamers as receptors, Anal. Biochem., 282, 142, 10.1006/abio.2000.4595
Lee, 2005, An RNA aptamer that binds to the beta-catenin interaction domain of TCF-1 protein, Biochem. Biophys. Res. Commun., 327, 294, 10.1016/j.bbrc.2004.12.011
Lee, 2006, In vitro selection of cancer-specific RNA aptamers, J. Microbiol. Biotechnol., 16, 1149
Leva, 2002, GnRH binding RNA and DNA Spiegelmers: a novel approach toward GnRH antagonism, Chem. Biol., 9, 351, 10.1016/S1074-5521(02)00111-4
Liss, 2002, An aptamer-based quartz crystal protein biosensor, Anal. Chem., 74, 4488, 10.1021/ac011294p
Liu, 2005, Combining SELEX with quantitative assays to rapidly obtain accurate models of protein–DNA interactions, Nucleic Acids Res., 33, e141, 10.1093/nar/gni139
Liu, 2006, Smart nanomaterials responsive to multiple chemical stimuli with controllable cooperativity, Adv. Mater., 18, 1667, 10.1002/adma.200600525
Lorsch, 1994, In vitro selection of RNA aptamers specific for cyanocobalamin, Biochemistry, 33, 973, 10.1021/bi00170a016
Lozupone, 2003, Selection of the simplest RNA that binds isoleucine, RNA, 9, 1315, 10.1261/rna.5114503
Lupold, 2002, Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen, Cancer Res., 62, 4029
Maberley, 2005, Pegaptanib for neovascular age-related macular degeneration, Issues Emerg. Health Technol., 1
Macaya, 1993, Thrombin-binding DNA aptamer forms a unimolecular quadruplex structure in solution, Proc. Natl. Acad. Sci. U. S. A., 90, 3745, 10.1073/pnas.90.8.3745
Majerfeld, 2005, RNA affinity for molecular l-histidine; genetic code origins, J. Mol. Evol., 61, 226, 10.1007/s00239-004-0360-9
Majerfeld, 1998, Isoleucine: RNA sites with associated coding sequences, RNA, 4, 471
Majerfeld, 1994, An RNA pocket for an aliphatic hydrophobe, Nat. Struct. Mol. Biol., 1, 287, 10.1038/nsb0594-287
Mallikaratchy, 2006, Selection of DNA ligands for protein kinase C-delta, Chem. Commun., 3229, 10.1039/b604778e
Mann, 2005, In vitro selection of DNA aptamers binding ethanolamine, Biochem. Biophys. Res. Commun., 338, 1928, 10.1016/j.bbrc.2005.10.172
Mannironi, 1997, In vitro selection of dopamine RNA ligands, Biochemistry, 36, 9726, 10.1021/bi9700633
Marro, 2005, Identification of potent and selective RNA antagonists of the IFN-gamma-inducible CXCL10 chemokine, Biochemistry, 44, 8449, 10.1021/bi048145w
Marshall, 2000, In vitro selection of RNA aptamers, Methods Enzymol., 318, 193, 10.1016/S0076-6879(00)18053-X
Martell, 2002, Optimizing aptamer activity for gene therapy applications using expression cassette SELEX, Mol. Ther., 6, 30, 10.1006/mthe.2002.0624
Masud, 2004, Sialyllactose-binding modified DNA aptamer bearing additional functionality by SELEX, Bioorg. Med. Chem., 12, 1111, 10.1016/j.bmc.2003.12.009
Meli, 2002, Adenine-aptamer complexes—A bipartite RNA site that binds the adenine nucleic base, J. Biol. Chem., 277, 2104, 10.1074/jbc.M107130200
Mendonsa, 2004, In vitro selection of high-affinity DNA ligands for human IgE using capillary electrophoresis, Anal. Chem., 76, 5387, 10.1021/ac049857v
Michaud, 2003, A DNA aptamer as a new target-specific chiral selector for HPLC, J. Am. Chem. Soc., 125, 8672, 10.1021/ja034483t
Misono, 2005, Selection of RNA aptamers against human influenza virus hemagglutinin using surface plasmon resonance, Anal. Biochem., 342, 312, 10.1016/j.ab.2005.04.013
Missailidis, 2005, Selection of aptamers with high affinity and high specificity against C595, an anti-MUC1 IgG3 monoclonal antibody, for antibody targeting, J. Immunol. Methods, 296, 45, 10.1016/j.jim.2004.10.011
Morris, 1998, High affinity ligands from in vitro selection: complex targets, Proc. Natl. Acad. Sci. U. S. A., 95, 2902, 10.1073/pnas.95.6.2902
Mosing, 2005, Capillary electrophoresis-SELEX selection of aptamers with affinity for HIV-1 reverse transcriptase, Anal. Chem., 77, 6107, 10.1021/ac050836q
Murphy, 2003, An improved method for the in vitro evolution of aptamers and applications in protein detection and purification, Nucleic Acids Res., 31, e110, 10.1093/nar/gng110
Naimuddin, 2007, Selection-by-function: efficient enrichment of cathepsin E inhibitors from a DNA library, J. Mol. Recognit., 20, 58, 10.1002/jmr.812
Nakamura, 2001, Usage of a DNA aptamer as a ligand targeting microcystin, Mol. Cryst. Liquid Cryst., 371, 369, 10.1080/10587250108024762
Nimjee, 2005, The potential of aptamers as anticoagulants, Trends Cardiovasc. Med., 15, 41, 10.1016/j.tcm.2005.01.002
Nimjee, 2005, Aptamers: an emerging class of therapeutics, Annu. Rev. Med., 56, 555, 10.1146/annurev.med.56.062904.144915
Nishikawa, 2004, In vitro selection of RNA aptamers against the HCVNS3 helicase domain, Oligonucleotides, 14, 114, 10.1089/1545457041526335
Nix, 2000, The 1.3 angstrom crystal structure of a biotin-binding pseudoknot and the basis for RNA molecular recognition, J. Mol. Biol., 296, 1235, 10.1006/jmbi.2000.3539
Nutiu, 2005, In vitro selection of structure-switching signaling aptamers, Angew. Chem. -Int. Edit., 44, 1061, 10.1002/anie.200461848
O'Sullivan, 2002, Aptasensors—the future of biosensing, Anal. Bioanal. Chem., 372, 44, 10.1007/s00216-001-1189-3
Ohuchi, 2006, Selection of RNA aptamers against recombinant transforming growth factor-beta type III receptor displayed on cell surface, Biochimie, 88, 897, 10.1016/j.biochi.2006.02.004
Okazawa, 2000, In vitro selection of hematoporphyrin binding DNA aptamers, Bioorg. Med. Chem. Lett., 10, 2653, 10.1016/S0960-894X(00)00540-0
Pan, 1995, Isolation of virus-neutralizing RNAs from a large pool of random sequences, Proc. Natl. Acad. Sci. U. S. A., 92, 11509, 10.1073/pnas.92.25.11509
Patel, 1997, Structural analysis of nucleic acid aptamers, Curr. Opin. Chem. Biol., 1, 32, 10.1016/S1367-5931(97)80106-8
Patel, 1997, Structure, recognition and adaptive binding in RNA aptamer complexes, J. Mol. Biol., 272, 645, 10.1006/jmbi.1997.1281
Petersen, 2003, LNA: a versatile tool for therapeutics and genomics, Trends Biotechnol., 21, 74, 10.1016/S0167-7799(02)00038-0
Pileur, 2003, Selective inhibitory DNA aptamers of the human RNase H1, Nucleic Acids Res., 31, 5776, 10.1093/nar/gkg748
Potyrailo, 1998, Adapting selected nucleic acid ligands (aptamers) to biosensors, Anal. Chem., 70, 3419, 10.1021/ac9802325
Proske, 2002, Prion-protein-specific aptamer reduces PrPSc formation, Chembiochemistry, 3, 717, 10.1002/1439-7633(20020802)3:8<717::AID-CBIC717>3.0.CO;2-C
Radrizzani, 1999, Oligobodies: bench made synthetic antibodies, Med.-Buenos Aires, 59, 753
Rajendran, 2003, In vitro selection of molecular beacons, Nucleic Acids Res., 31, 5700, 10.1093/nar/gkg764
Ravelet, 2006, Liquid chromatography, electrochromatography and capillary electrophoresis applications of DNA and RNA aptamers, J. Chromatogr. A, 1117, 1, 10.1016/j.chroma.2006.03.101
Rhie, 2003, Characterization of 2′-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion, J. Biol. Chem., 278, 39697, 10.1074/jbc.M305297200
Rhodes, 2000, The generation and characterization of antagonist RNA aptamers to human oncostatin M, J. Biol. Chem., 275, 28555, 10.1074/jbc.M002981200
Rhodes, 2001, The generation and characterisation of antagonist RNA aptamers to MCP-1, FEBS Lett., 506, 85, 10.1016/S0014-5793(01)02895-2
Rimmele, 2003, Nucleic acid aptamers as tools and drugs: recent developments, Chembiochemistry, 4, 963, 10.1002/cbic.200300648
Ringquist, 1995, High-affinity RNA ligands to Escherichia coli ribosomes and ribosomal protein S1: comparison of natural and unnatural binding sites, Biochemistry, 34, 3640, 10.1021/bi00011a019
Roulet, 2002, High-throughput SELEX-SAGE method for quantitative modeling of transcription-factor binding sites, Nat. Biotechnol., 20, 831, 10.1038/nbt718
Ruckman, 1998, 2′-fluoropyrimidine RNA-based aptamers to the 165-amino acid form of vascular endothelial growth factor (VEGF(165))—inhibition of receptor binding and VEGF-induced vascular permeability through interactions requiring the exon 7-encoded domain, J. Biol. Chem., 273, 20556, 10.1074/jbc.273.32.20556
Rusconi, 2004, Antidote-mediated control of an anticoagulant aptamer in vivo, Nat. Biotechnol., 22, 1423, 10.1038/nbt1023
Saito, 2005, Generation of inhibitory DNA aptamers against human hepatocyte growth factor, DNA Cell Biol., 24, 624, 10.1089/dna.2005.24.624
Sampson, 2003, Aptamers and SELEX: the technology, World Patent Inf., 25, 123, 10.1016/S0172-2190(03)00035-8
Saran, 2003, The tyranny of adenosine recognition among RNA aptamers to coenzyme A, BMC Evol. Biol., 3
Sazani, 2004, A small aptamer with strong and specific recognition of the triphosphate of ATP, J. Am. Chem. Soc., 126, 8370, 10.1021/ja049171k
Schmidt, 2004, Application of locked nucleic acids to improve aptamer in vivo stability and targeting function, Nucleic Acids Res., 32, 5757, 10.1093/nar/gkh862
Schneider, 1999, A molecular dynamics simulation of the flavin mononucleotide-RNA aptamer complex, Biopolymers, 50, 287, 10.1002/(SICI)1097-0282(199909)50:3<287::AID-BIP5>3.0.CO;2-G
Schneider, 1993, Selective enrichment of RNA species for tight-binding to Escherichia-Coli Rho-factor, FASEB J., 7, 201, 10.1096/fasebj.7.1.7678562
Schneider, 1995, High-affinity ssdna inhibitors of the reverse-transcriptase of type-1 human-immunodeficiency-virus, Biochemistry, 34, 9599, 10.1021/bi00029a037
Schürer, 2001, Aptamers that bind to the antibiotic moenomycin A, Bioorg. Med. Chem., 9, 2557, 10.1016/S0968-0896(01)00030-X
Seiwert, 2000, RNA aptamers as pathway-specific MAP kinase inhibitors, Chem. Biol., 7, 833, 10.1016/S1074-5521(00)00032-6
Sekiya, 2006, Characterization and application of a novel RNA aptamer against the mouse prion protein, J. Biochem., 139, 383, 10.1093/jb/mvj046
Sekkal, 2002, In vitro selection of DNA aptamers against the HIV-1 TAR RNA hairpin, Antisense Nucleic Acid Drug Dev., 12, 265, 10.1089/108729002320351584
Shangguan, 2006, Aptamers evolved from live cells as effective molecular probes for cancer study, Proc. Natl. Acad. Sci. U. S. A., 103, 11838, 10.1073/pnas.0602615103
Shi, 2002, Evolutionary dynamics and population control during in vitro selection and amplification with multiple targets, RNA-A, 8, 1461, 10.1017/S1355838202029941
Shimada, 2005, Systematic search for the Cra-binding promoters using genomic SELEX system, Genes Cells, 10, 907, 10.1111/j.1365-2443.2005.00888.x
Smith, 1995, In-vitro selection of RNA-based irreversible inhibitors of human neutrophil elastase, Chem. Biol., 2, 741, 10.1016/1074-5521(95)90102-7
Soukup, 1999, Relationship between internucleotide linkage geometry and the stability of RNA, RNA-A, 5, 1308, 10.1017/S1355838299990891
Srisawat, 2001, Streptavidin aptamers: affinity tags for the study of RNAs and ribonucleoproteins, RNA, 7, 632, 10.1017/S135583820100245X
Srisawat, 2001, Sephadex-binding RNA ligands: rapid affinity purification of RNA from complex RNA mixtures, Nucleic Acids Res., 29, E4, 10.1093/nar/29.2.e4
Stelzl, 2001, SERF: in vitro selection of random RNA fragments to identify protein binding sites within large RNAs, Methods, 25, 351, 10.1006/meth.2001.1247
Stojanovic, 2000, Fluorescent sensors based on aptamer self-assembly, J. Am. Chem. Soc., 122, 11547, 10.1021/ja0022223
Stoltenburg, 2005, FluMag-SELEX as an advantageous method for DNA aptamer selection, Anal. Bioanal. Chem., 383, 83, 10.1007/s00216-005-3388-9
Tahiri-Alaoui, 2002, High affinity nucleic acid aptamers for streptavidin incorporated into bi-specific capture ligands, Nucleic Acids Res., 30, e45, 10.1093/nar/30.10.e45
Takemura, 2006, DNA aptamers that bind to PrPC and not PrPSc show sequence and structure specificity, Exp. Biol. Med., 231, 204, 10.1177/153537020623100211
Tang, 2006, The DNA aptamers that specifically recognize ricin toxin are selected by two in vitro selection methods, Electrophoresis, 27, 1303, 10.1002/elps.200500489
Tang, 2007, In vitro selection of DNA aptamer against abrin toxin and aptamer-based abrin direct detection, Biosens. Bioelectron., 22, 2456, 10.1016/j.bios.2006.09.015
Theis, 2004, Discriminatory aptamer reveals serum response element transcription regulated by cytohesin-2, Proc. Natl. Acad. Sci. U. S. A., 101, 11221, 10.1073/pnas.0402901101
Thiel, 2004, Oligo oligarchy—the surprisingly small world of aptamers, Nat. Biotechnol., 22, 649, 10.1038/nbt0604-649
Thompson, 1994, CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice, Nucleic Acids Res., 22, 4673, 10.1093/nar/22.22.4673
Tombelli, 2005, Aptamer-based biosensors for the detection of HIV-1 Tat protein, Bioelectrochemistry, 67, 135, 10.1016/j.bioelechem.2004.04.011
Tombelli, 2005, Analytical applications of aptamers, Biosens. Bioelectron., 20, 2424, 10.1016/j.bios.2004.11.006
Toulme, 2003, Modulating viral gene expression by aptamers to RNA structures, Biol. Cell., 95, 229, 10.1016/S0248-4900(03)00036-4
Tsai, 1998, Identification of DNA recognition sequences and protein interaction domains of the multiple-Zn-finger protein Roaz, Mol. Cell. Biol., 18, 6447, 10.1128/MCB.18.11.6447
Tucker, 1999, Detection and plasma pharmacokinetics of an anti-vascular endothelial growth factor oligonucleotide-aptamer (NX1838) in rhesus monkeys, J. Chromatogr. B, 732, 203, 10.1016/S0378-4347(99)00285-6
Tuerk, 1990, Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase, Science, 249, 505, 10.1126/science.2200121
Tuerk, 1992, RNA pseudoknots that inhibit human-immunodeficiency-virus type-1 reverse-transcriptase, Proc. Natl. Acad. Sci. U. S. A., 89, 6988, 10.1073/pnas.89.15.6988
Ulrich, 2002, In vitro selection of RNA aptamers that bind to cell adhesion receptors of Trypanosoma cruzi and inhibit cell invasion, J. Biol. Chem., 277, 20756, 10.1074/jbc.M111859200
Ulrich, 2004, RNA and DNA aptamers in cytomics analysis, Cytom. Part A., 59A, 220, 10.1002/cyto.a.20056
Ulrich, 2006, DNA and RNA aptamers: from tools for basic research towards therapeutic applications, Comb. Chem. High Throughput Screen., 9, 619, 10.2174/138620706778249695
Vaish, 2003, A novel, modification-dependent ATP-binding aptamer selected from an RNA library incorporating a cationic functionality, Biochemistry, 42, 8842, 10.1021/bi027354i
Vater, 2003, Short bioactive Spiegelmers to migraine-associated calcitonin gene-related peptide rapidly identified by a novel approach: tailored-SELEX, Nucleic Acids Res., 31, e130, 10.1093/nar/gng130
Vianini, 2001, In vitro selection of DNA aptamers that bind l-tyrosinamide, Bioorg. Med. Chem., 9, 2543, 10.1016/S0968-0896(01)00054-2
Walder, 1993, Use of PCR primers containing a 3’-terminal ribose residue to prevent cross-contamination of amplified sequences, Nucleic Acids Res., 21, 4339, 10.1093/nar/21.18.4339
Wallace, 1998, In vitro selection and characterization of streptomycin-binding RNAs: recognition discrimination between antibiotics, RNA, 4, 112
Wallis, 1995, A novel RNA motif for neomycin recognition, Chem. Biol., 2, 543, 10.1016/1074-5521(95)90188-4
Wang, 2003, Single-stranded DNA aptamers that bind differentiated but not parental cells: subtractive systematic evolution of ligands by exponential enrichment, J. Biotechnol., 102, 15, 10.1016/S0168-1656(02)00360-7
Wang, 1995, Specific binding of aminoglycoside antibiotics to RNA, Chem. Biol., 2, 281, 10.1016/1074-5521(95)90047-0
Weiss, 1997, RNA aptamers specifically interact with the prion protein PrP, J. Virol., 71, 8790, 10.1128/JVI.71.11.8790-8797.1997
Wen, 2004, Selection of genomic sequences that bind tightly to Ff gene 5 protein: primer-free genomic SELEX, Nucleic Acids Res., 32, e182, 10.1093/nar/gnh179
White, 2001, Generation of species cross-reactive aptamers using “toggle” SELEX, Mol. Ther., 4, 567, 10.1006/mthe.2001.0495
White, 2003, Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2, Proc. Natl. Acad. Sci. U. S. A., 100, 5028, 10.1073/pnas.0831159100
Wiegand, 1996, High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I, J. Immunol., 157, 221, 10.4049/jimmunol.157.1.221
Williams, 1995, PCR product with strands of unequal length, Nucleic Acids Res., 23, 4220, 10.1093/nar/23.20.4220
Williams, 1997, Bioactive and nuclease-resistant l-DNA ligand of vasopressin, Proc. Natl. Acad. Sci. U. S. A., 94, 11285, 10.1073/pnas.94.21.11285
Wilson, 1998, Functional requirements for specific ligand recognition by a biotin-binding RNA pseudoknot, Biochemistry, 37, 14410, 10.1021/bi981371j
Wilson, 1998, Isolation of a fluorophore-specific DNA aptamer with weak redox activity, Chem. Biol., 5, 609, 10.1016/S1074-5521(98)90289-7
Wilson, 1999, In vitro selection of functional nucleic acids, Ann. Rev. Biochem., 68, 611, 10.1146/annurev.biochem.68.1.611
Yan, 2005, Aptamers: prospects in therapeutics and biomedicine, Front. Biosci., 10, 1802, 10.2741/1663
Yang, 1998, DNA ligands that bind tightly and selectively to cellobiose, Proc. Natl. Acad. Sci. U. S. A., 95, 5462, 10.1073/pnas.95.10.5462
Yang, 2003, Immunofluorescence assay and flow-cytometry selection of bead-bound aptamers, Nucleic Acids Res., 31, e54, 10.1093/nar/gng054
Ylera, 2002, Selection of RNA aptamers to the Alzheimer's disease amyloid peptide, Biochem. Biophys. Res. Commun., 290, 1583, 10.1006/bbrc.2002.6354
Yoshida, 2006, Aptameric enzyme subunit for biosensing based on enzymatic activity measurement, Anal. Chem., 78, 3296, 10.1021/ac060254o
Zhan, 2005, Screening and characterization of aptamers of hepatitis C virus NS3 helicase, Progr. Biochem. Biophys., 32, 245
Zolotukhin, 2001, Retroviral constitutive transport element evolved from cellular TAP(NXF1)-binding sequences, J. Virol., 75, 5567, 10.1128/JVI.75.12.5567-5575.2001